CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...